Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOSTB4: Fetal MSCs for Severe Osteogenesis Imperfecta
NCT03706482Phase 2Active, not recruiting
- Sponsor
- Karolinska Institutet
- Start
- Aug 2019
- Primary completion
- Apr 2030
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic expanded fetal mesenchymal stem cells in osteogenesis imperfecta (OI), sponsored by Karolinska Institutet. Started Aug 2019; status: active, not recruiting.
02
Drugs
allogeneic expanded fetal mesenchymal stem cells
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT03706482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706482.